Dianhydrogalactitol (VAL-083) in combination with AZD1775 increases survival in diffuse intrinsic pontine glioma (DIPG), in vivo

被引：0
|
作者：
Steino, Anne [1 ]
Yang, Xiaodong [2 ]
Kline, Cassie [2 ]
Bacha, Jeffrey [1 ]
Brown, Dennis M. [3 ]
Mueller, Sabine [2 ]
机构：
[1] Delmar Pharmaceut Inc, Vancouver, BC, Canada
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Delmar Pharmaceut Inc, Menlo Pk, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3499
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3499
引用
收藏
页数：2
相关论文
共 38 条
  • [1] DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO
    Steino, Anne
    Yang, Xiaodong
    Kline, Cassie
    Brown, Dennis
    Bacha, Jeff
    Liu, Lei
    Mueller, Sabine
    NEURO-ONCOLOGY, 2019, 21 : 77 - 77
  • [2] VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
    Subramaniam, Bavani
    Roy, Debasish
    Woldegerima, Ayda
    Przystal, Justyna
    Zhang, Jie
    Laternser, Sandra
    Kritzer, Bettina
    Yadavilli, Sridevi
    Mueller, Sabine
    Packer, Roger
    Nazarian, Javad
    NEURO-ONCOLOGY, 2024, 26
  • [3] PRECLINICAL STUDIES OF DIANHYDROGALACTITOL (VAL-083) IN DIPG, AS SINGLE AGENT OR AS A COMBINATION WITH RADIATION OR AZD1775
    Steino, Anne
    Bacha, Jeffrey
    Brown, Dennis
    Mueller, Sabine
    NEURO-ONCOLOGY, 2018, 20 : 60 - 60
  • [4] DIANHYDROGALACTITOL (VAL-083) HAS THE POTENTIAL TO OVERCOME MAJOR CHALLENGES IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Steino, Anne
    Zhai, BeiBei
    Yang, Xiaodong
    Kline, Cassie
    Bacha, Jeffrey
    Brown, Dennis
    Daugaard, Mads
    Mueller, Sabine
    NEURO-ONCOLOGY, 2018, 20 : 86 - 86
  • [5] PONTINE MEASUREMENTS PREDICT SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Steffen-Smith, Emilie
    Venzon, David
    Bent, Robyn
    Baker, Eva
    Shandilya, Shaefali
    Warren, Katherine
    NEURO-ONCOLOGY, 2012, 14 : 141 - 142
  • [6] COMBINATION OF ARGININE DEPLETION AND POLYAMINE INHIBITION AS AN ANTICANCER STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Khan, Aaminah
    Gamble, Laura
    Pandher, Ruby
    Burns, Mark R.
    Mussai, Francis
    Norris, Murray
    Haber, Michelle
    Tsoli, Maria
    Ziegler, David S.
    NEURO-ONCOLOGY, 2020, 22 : 290 - 290
  • [7] Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation
    Janssens, G. O. R. J.
    Bolle, S.
    Mandeville, H.
    Ramos-Albiac, M.
    Van Beek, K.
    Benghiat, H.
    Hoeben, B.
    Morales la Madrid, A.
    Peters, M.
    Kortmann, R.
    Von Bueren, A. O.
    Van Vuurden, D.
    Kramm, C. M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S360 - S360
  • [8] PHASE 1 TRIAL OF MARIZOMIB ALONE AND IN COMBINATION WITH PANOBINOSTAT IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Warren, K. E.
    Greenspan, L.
    Strachan, M.
    Plant, A.
    Chi, S. N.
    Vogelzang, J.
    Ligon, K.
    Alexandrescu, S.
    Baxter, P. A.
    Vitanza, N.
    Chen, N.
    Coraccio, K.
    Yuan, Y.
    London, W. B.
    Monje, M.
    NEURO-ONCOLOGY, 2023, 25
  • [9] PRECLINICAL EVALUATION OF DASATINIB ALONE AND IN COMBINATION WITH CABOZANTINIB FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) IN CHILDREN
    Truffaux, Nathalene
    Philippe, Cathy
    Cornilleau, Gaetan
    Paulsson, Janna
    Andreiuolo, Felipe
    Guerrini-Rousseau, Lea
    Puget, Stephanie
    Geoerger, Birgit
    Vassal, Gilles
    Ostman, Arne
    Grill, Jacques
    NEURO-ONCOLOGY, 2014, 16 : 55 - 55
  • [10] DEVELOPMENT OF IN VIVO MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) FROM STEREOTACTIC BIOPSIES PERFORMED AT DIAGNOSIS
    Plessier, Alexandre
    Le Dret, Ludivine
    Fiette, Laurence
    Meriaux, Sebastien
    Beccaria, Kevin
    Varlet, Pascale
    Puget, Stephanie
    Grill, Jacques
    Debily, Marie-Anne
    Castel, David
    NEURO-ONCOLOGY, 2016, 18 : 60 - 60
1234